Gastro‐intestinal bleeding in acquired von Willebrand's disease: efficacy of high‐dose immuno‐globulin where substitution treatments failed
- 1 June 1993
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 84 (2) , 332-334
- https://doi.org/10.1111/j.1365-2141.1993.tb03074.x
Abstract
Summary. We report a case of acquired von Willebrand's disease with severe and persistent gastro‐intestinal bleeding from multiple bleeding points. He received maximum substitution treatment including factor VIII concentrates, cryoprecipitate and platelets. He also received DDAVP. There was no change in the rate of blood loss. He was then treated with high‐dose intravenous gammaglobulin and the blood loss stopped abruptly. He remained well for several months when bleeding recommenced and he again responded promptly to gamma‐globulin. This is a useful maintenance treatment for patients with acquired von Willebrand's disease.Keywords
This publication has 5 references indexed in Scilit:
- EFFICACY OF HIGH‐DOSE INTRAVENOUS GAMMAGLOBULIN IN THE MANAGEMENT OF ACQUIRED VON WILLEBRAND'S DISEASE DURING ORTHOPAEDIC SURGERYBritish Journal of Haematology, 1992
- Successful Treatment of an Acquired von Willebrand Factor Antibody by Extracorporeal ImmunoadsorptionNew England Journal of Medicine, 1989
- HIGH‐DOSE INTRAVENOUS GAMMAGLOBULIN FOR ACQUIRED VON WILLEBRAND'S DISEASEBritish Journal of Haematology, 1988
- Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor‐platelet interaction and response to treatmentBritish Journal of Haematology, 1988
- Shear stress activation of platelet glycoprotein IIb/IIIa plus von Willebrand factor causes aggregation: filter blockage and the long bleeding time in von Willebrand's diseaseBlood, 1987